We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
RE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.
- Authors
Freidlin, Boris; Korn, Edward L.
- Abstract
A response from the author of the article "Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval" in the previous issue is presented.
- Subjects
ANTINEOPLASTIC agents; DRUG therapy; DRUG approval; PHARMACODYNAMICS
- Publication
JNCI: Journal of the National Cancer Institute, 2016, Vol 108, Issue 3, p1
- ISSN
0027-8874
- Publication type
commentary
- DOI
10.1093/jnci/djv430